Empirical estimate for the indirect healthcare costs of sickle cell disease from a retrospective cohort study in England between 2007 and 2019
{{output}}
Background: Sickle cell disease (SCD) imposes a considerable burden on patients and their families while also exerting economic pressure on high-prevalence countries. This retrospective cohort study estimated the societal cost of... ...
